ENTA – Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals, Inc.ENTA
$11.08Name : Enanta Pharmaceuticals, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $319,690,400.00
EPSttm : -4.32
Enanta Pharmaceuticals, Inc.
$11.08
2.38%$0.27Float Short %
10.94
Margin Of Safety %
Put/Call OI Ratio
0.49
EPS Next Q Diff
-0.17
EPS Last/This Y
1.76
EPS This/Next Y
0.44
Price
11.07
Target Price
19.14
Analyst Recom
1.43
Performance Q
55.4
Relative Volume
0.88
Beta
0.89
Ticker: ENTA
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-09-08 | ENTA | 8.96 | 0.10 | 0.00 | 2773 |
| 2025-09-09 | ENTA | 9.05 | 0.10 | 0.00 | 2776 |
| 2025-09-10 | ENTA | 8.3 | 0.11 | 0.84 | 2779 |
| 2025-09-11 | ENTA | 8.65 | 0.13 | 0.00 | 2939 |
| 2025-09-12 | ENTA | 8.28 | 0.12 | 0.00 | 3208 |
| 2025-09-15 | ENTA | 7.69 | 0.11 | 2.83 | 3365 |
| 2025-09-16 | ENTA | 7.44 | 0.16 | 0.00 | 3563 |
| 2025-09-17 | ENTA | 7.54 | 0.16475972540046 | 0 | 3563 |
| 2025-09-18 | ENTA | 7.86 | 0.16 | 0.00 | 3563 |
| 2025-09-19 | ENTA | 7.63 | 0.16 | 999.99 | 3665 |
| 2025-09-22 | ENTA | 7.69 | 0.10 | 0.00 | 2907 |
| 2025-09-23 | ENTA | 7.18 | 0.11 | 2.07 | 2949 |
| 2025-09-24 | ENTA | 7.82 | 0.17 | 0.00 | 3112 |
| 2025-09-25 | ENTA | 7.76 | 0.16 | 0.17 | 3223 |
| 2025-09-26 | ENTA | 7.94 | 0.17 | 0.01 | 3183 |
| 2025-09-29 | ENTA | 15.11 | 0.12 | 0.43 | 4321 |
| 2025-09-30 | ENTA | 11.97 | 0.35 | 2.08 | 5502 |
| 2025-10-01 | ENTA | 10.6 | 0.42 | 1.31 | 5902 |
| 2025-10-02 | ENTA | 10.3 | 0.49 | 0.79 | 6867 |
| 2025-10-03 | ENTA | 10.31 | 0.49 | 0.06 | 7014 |
| 2025-10-06 | ENTA | 11.35 | 0.48 | 0.20 | 7096 |
| 2025-10-07 | ENTA | 11.07 | 0.49 | 0.97 | 7142 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-09-08 | ENTA | 8.91 | 25.4 | - | -3.72 |
| 2025-09-09 | ENTA | 9.00 | 25.4 | - | -3.72 |
| 2025-09-10 | ENTA | 8.31 | 25.4 | - | -3.72 |
| 2025-09-11 | ENTA | 8.66 | 25.4 | - | -3.72 |
| 2025-09-12 | ENTA | 8.28 | 25.4 | - | -3.72 |
| 2025-09-15 | ENTA | 7.46 | 25.4 | - | -3.72 |
| 2025-09-16 | ENTA | 7.45 | 25.4 | - | -3.72 |
| 2025-09-17 | ENTA | 7.57 | 25.4 | - | -3.72 |
| 2025-09-18 | ENTA | 7.86 | 25.4 | - | -3.72 |
| 2025-09-19 | ENTA | 7.63 | 25.4 | - | -3.72 |
| 2025-09-22 | ENTA | 7.70 | 25.4 | - | -3.72 |
| 2025-09-23 | ENTA | 7.20 | 25.4 | - | -3.72 |
| 2025-09-24 | ENTA | 7.83 | 25.4 | - | -3.72 |
| 2025-09-25 | ENTA | 7.75 | 25.4 | - | -3.72 |
| 2025-09-26 | ENTA | 7.90 | 25.4 | - | -3.72 |
| 2025-09-29 | ENTA | 15.25 | 25.4 | - | -3.72 |
| 2025-09-30 | ENTA | 11.99 | 25.4 | - | -3.72 |
| 2025-10-01 | ENTA | 10.60 | 25.4 | - | -3.72 |
| 2025-10-02 | ENTA | 10.34 | 25.4 | - | -3.72 |
| 2025-10-03 | ENTA | 10.34 | 25.4 | - | -3.72 |
| 2025-10-06 | ENTA | 11.37 | 25.4 | - | -3.72 |
| 2025-10-07 | ENTA | 11.07 | 25.4 | - | -3.72 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-09-08 | ENTA | 0.00 | -2.01 | 14.53 |
| 2025-09-09 | ENTA | 0.00 | -2.01 | 14.53 |
| 2025-09-10 | ENTA | 0.00 | -2.01 | 14.53 |
| 2025-09-11 | ENTA | 0.00 | -2.01 | 14.27 |
| 2025-09-12 | ENTA | 0.00 | -2.01 | 14.27 |
| 2025-09-15 | ENTA | 0.00 | -1.86 | 14.27 |
| 2025-09-16 | ENTA | 0.00 | -1.86 | 14.27 |
| 2025-09-17 | ENTA | 0.00 | -1.86 | 14.27 |
| 2025-09-18 | ENTA | 0.00 | -1.86 | 14.27 |
| 2025-09-19 | ENTA | 0.00 | -1.86 | 14.27 |
| 2025-09-22 | ENTA | 0.00 | -1.89 | 14.27 |
| 2025-09-23 | ENTA | 0.00 | -1.89 | 14.27 |
| 2025-09-24 | ENTA | 0.00 | -1.89 | 14.27 |
| 2025-09-25 | ENTA | 0.00 | -1.89 | 14.34 |
| 2025-09-26 | ENTA | 0.00 | -1.89 | 14.34 |
| 2025-09-29 | ENTA | 0.00 | -1.89 | 14.26 |
| 2025-09-30 | ENTA | 0.00 | -1.89 | 14.26 |
| 2025-10-01 | ENTA | 0.00 | -1.89 | 14.26 |
| 2025-10-02 | ENTA | 0.00 | -1.89 | 14.26 |
| 2025-10-03 | ENTA | 0.00 | -1.89 | 14.26 |
| 2025-10-06 | ENTA | 0.00 | -1.39 | 0 |
| 2025-10-07 | ENTA | 0.00 | -1.39 | 10.94 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.85
Avg. EPS Est. Current Quarter
-1.01
Avg. EPS Est. Next Quarter
-1.02
Insider Transactions
Institutional Transactions
-1.39
Beta
0.89
Average Sales Estimate Current Quarter
15
Average Sales Estimate Next Quarter
16
Fair Value
Quality Score
20
Growth Score
26
Sentiment Score
53
Actual DrawDown %
89.2
Max Drawdown 5-Year %
-95.6
Target Price
19.14
P/E
Forward P/E
PEG
P/S
4.93
P/B
2.99
P/Free Cash Flow
EPS
-4.32
Average EPS Est. Cur. Y
-3.72
EPS Next Y. (Est.)
-3.27
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-141.98
Relative Volume
0.88
Return on Equity vs Sector %
-141.3
Return on Equity vs Industry %
-127.6
EPS 1 7Days Diff
EPS 1 30Days Diff
0.5
EBIT Estimation
Enanta Pharmaceuticals, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 131
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
stock quote shares ENTA – Enanta Pharmaceuticals Inc Stock Price stock today
news today ENTA – Enanta Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ENTA – Enanta Pharmaceuticals Inc yahoo finance google finance
stock history ENTA – Enanta Pharmaceuticals Inc invest stock market
stock prices ENTA premarket after hours
ticker ENTA fair value insiders trading